Melanoma recurrence risk cut by 49% by new vaccine/existing drug combo

Combining a new melanoma vaccine with an existing drug significantly reduced the risk of the cancer recurring. Depositphotos – By Paul McClure 2024 Jun 03 Results from human trials coupling a new melanoma vaccine with an existing cancer drug showed that, at the three-year …